Radioimmunoassay of Antarelix(TM), a luteinizing hormone releasing- hormone antagonist, in plasma and its application for pharmacokinetic study in dogs

Journal of Immunoassay

Volumn 17, Issue 3, 1996, Pages 205-226

  Sorensen, Suzie ^a   Rondeau, Jean Jacques ^a   Lenaerts, Vincent ^b   Boutignon, François ^b   Wüthrich, Patrick ^b   Deghenghi, Romano ^b   Adam, Albert ^a   Ong, Huy ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b Ardana   (France)

Author keywords

Antarelix(TM); LHRH Antagonist; Pharmacokinetics; Radioimmunoassay; Teverelix

Indexed keywords

GONADORELIN ANTAGONIST; TEVERELIX; UNCLASSIFIED DRUG; GONADORELIN; HORMONE ANTAGONIST; OLIGOPEPTIDE;

ANIMAL EXPERIMENT; ARTICLE; CROSS REACTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG BLOOD LEVEL; DRUG MONITORING; DRUG PROTEIN BINDING; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; RADIOIMMUNOASSAY; SUBCUTANEOUS DRUG ADMINISTRATION; ANIMAL; BLOOD; DOG; DRUG ANTAGONISM;

ANIMALS; CROSS REACTIONS; DOGS; GONADOTROPIN-RELEASING HORMONE; HORMONE ANTAGONISTS; OLIGOPEPTIDES; RADIOIMMUNOASSAY;

EID: 0029657989     PISSN: 01971522     EISSN: None     Source Type: Journal    
DOI: 10.1080/01971529608005789     Document Type: Article

References (9)

1. Karten, M.J. An overview of GnRH Antagonist Developpement: Two Decades of Progress. In: Crowley, W.F. and Conn P.M., eds. Modes of Action of GnRH and GnRH Analogs. New York: Springer-Verlag, 1992:277-97.
2. Pavlou, S.N. GnRH antagonists in men. In: Crowley, W.F. and Conn, P.M., eds. Modes of Action of GnRH and GnRH Analogs. New York: Springer-Verlag, 1992:298-309.
3. Deghenghi, R., Boutignon, F., Wüthrich, P. and Lenaerts, V. Antarelix (EP 24332) a Novel Water Soluble LH-RH Antagonist. Biomed. Pharmacother. 1993; 47: 107-10.
4. De Léan, A., Munson, P.J. and Rodbard, D. Simultaneous Analysis of Families of Sigmoidal Curves: Application to Bioassay, Radioligand Assay, and Physiological Dose-Response Curves. Am. J.Physiol. 1978; 235: E97-102.
5. Gibaldi, M. Biopharmaceutics and clinical pharmacokinetics. Philadelphia: Lea and Febiger, 1991: 14-23.
6. Ljungqvist, A., Feng D.M., Hook, W., Shen, Z.X., Bowers, C. and Folkers, K. Antide and Related Antagonists of Luteinizing Hormone Release with Long Action and Oral Activity. Proc. Natl. Acad Sci. USA 1985; 85: 8236-40.
7. Chan, R.L., Ho, W., Webb, A.S., LaFargue, J. and Nerenberg C.A. Disposition of Detirelix, a Potent Luteinizing Hormone-Releasing Hormone Antagonist, in Rats and Monkeys. Pharm. Res. 1988; 5: 335-40.
8. Chan, R.L., Haroldsen, P.E., Ho, W. and Nestor, J.J. Disposition of RS-26306, a Potent Luteinizing Hormone-Releasing Hormone Antagonist, in Monkey and Rats after Single Intravenous and Subcutaneous Administration. Drug Metab. Dispos. Biol. Fate Chem. 1991; 19: 858-64.
9. Powell, M.F., Sanders, M.L., Rogerson, A. and Si, Vi. Parenteral peptide formulations: Chemical and physical properties of native luteinizing hormone releasing hormone (LHRH) and hydrophobic analogues in aqueous solution. Pharm. Res. 1991; 8: 1258-63.